Replies to post #356024 on Amarin Corp Plc (AMRN)

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[Number sleven]

Raf, Am I correct in assuming that these numbers don't include any sales from Germany?
Sleven,

[ggwpq]

Thanks raf for the numbers. I am confident in KM's new strategy.

[ralphey]

New Vascepa Rx's 37,000 (CAD Indication)


New Lovaza / gV 41,800 (VHTG Indication)


So I guess the prevalence of VHTG is greater than the prevalence of CAD.


Houston ... we have a problem

[Examiner77]

Raf, thank you for the scripts !
We are almost at Q2 total scripts with 4 more days remaining.
I believe we will end the quarter with a 5% increase compared to Q2.

[lizzy241]

Thanks Raf for script numbers. Maybe some of the docs here that reside in the EU know of a way to obtain a main source of that data, maybe something similar to a Symphony type company/organization that is located in each country??

[rafunrafun]

Scripts for week ending October 1, 2021

Overall drug TRx are +1.1% w/w

Vascepa
TRx 81,199; -1.8% (-1,468) w/w; -11.4% y/y
NRx 37,243; -0.4% (-151) w/w; -13.1% y/y
Ref 43,956; -2.9% (-1,317) w/w; -9.9% y/y

Lovaza (Generic & Brand)
TRx 63,136; -1.6% (-1,054) w/w; -0.8% y/y
NRx 31,085; -0.3% (-81) w/w; -3.3% y/y
Ref 32,051; -2.9% (-973) w/w; +1.7% y/y

Generic Vascepa
TRx 18,591; -2.9% (-552) w/w; As % of total V: 18.6%
NRx 10,568; -1.8% (-189) w/w; As % of total V: 22.1%
Ref 8,023; -4.3% (-363) w/w; As % of total V: 15.4%

Generic Vascepa by Manufacturer
Hikma - TRx 12,131 (-622); Generic share 65.3%; Total V share 12.2%
Reddy - TRx 6,460 (+69); Generic share 34.7%; Total V share 6.5%

TRx Vascepa + Generic Vascepa: 99,790 (-2,020)